SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer
NCT07391813
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
Interventions
DRUG:
SNB-101
Sponsor
SN BioScience